Cross-reactive antibody response to Monkeypox virus surface proteins in a small proportion of individuals with and without Chinese smallpox vaccination history

• Published in: BMC biology 2023-10, Vol.21 (1), p.205-15, Article 205
• Main Authors: Xia, Anqi, Wang, Xiaojie, He, Jiaying, Wu, Wei, Jiang, Weiyu, Xue, Song, Zhang, Qianqian, Gao, Yidan, Han, Yuru, Li, Yaming, Peng, Xiaofang, Xie, Minxiang, Mayer, Christian T, Liu, Jie, Hua, Chen, Sha, Yiou, Xu, Wei, Huang, Jinghe, Ying, Tianlei, Jiang, Shibo, Xie, Youhua, Cai, Qiliang, Lu, Lu, Silva, Israel T, Yuan, Zhenghong, Zhang, Yixiao, Wang, Qiao
• Format: Article
• Language: English
• Subjects: Amino acids; Animals; Antibodies; Antibody; Antibody Formation; Antibody response; Antigen-antibody reactions; Antigens; China; Cross Reactions; Cross-reactivity; East Asian People; Enzyme-linked immunosorbent assay; Females; Health aspects; Human monkeypox; Humans; Infections; Membrane Proteins; Mice; Monkeypox virus; Mortality; Mpox; Mpox (monkeypox); Neutralization; Orthopoxvirus; Patient outcomes; Physiological aspects; Prevention; Proteins; Public health; Risk factors; Serological ELISA; Smallpox; Smallpox - prevention & control; Smallpox vaccination; Smallpox vaccine; Smallpox Vaccine - immunology; Smallpox Vaccine - therapeutic use; Vaccination; Vaccines; Vaccinia virus; VACV Tiantan Strain; Viral infections; Viral proteins; Virus research; Viruses; Young Adult; Young adults
• ISSN: 1741-7007; 1741-7007
• DOI: 10.1186/s12915-023-01699-8

After the eradication of smallpox in China in 1979, vaccination with the vaccinia virus (VACV) Tiantan strain for the general population was stopped in 1980. As the monkeypox virus (MPXV) is rapidly spreading in the world, we would like to investigate whether the individuals with historic VACV Tiantan strain vaccination, even after more than 40 years, could still provide ELISA reactivity and neutralizing protection; and whether the unvaccinated individuals have no antibody reactivity against MPXV at all. We established serologic ELISA to measure the serum anti-MPXV titer by using immunodominant MPXV surface proteins, A35R, B6R, A29L, and M1R. A small proportion of individuals (born before 1980) with historic VACV Tiantan strain vaccination exhibited serum ELISA cross-reactivity against these MPXV surface proteins. Consistently, these donors also showed ELISA seropositivity and serum neutralization against VACV Tiantan strain. However, surprisingly, some unvaccinated young adults (born after 1980) also showed potent serum ELISA activity against MPXV proteins, possibly due to their past infection by some self-limiting Orthopoxvirus (OPXV). We report the serum ELISA cross-reactivity against MPXV surface protein in a small proportion of individuals both with and without VACV Tiantan strain vaccination history. Combined with our serum neutralization assay against VACV and the recent literature about mice vaccinated with VACV Tiantan strain, our study confirmed the anti-MPXV cross-reactivity and cross-neutralization of smallpox vaccine using VACV Tiantan strain. Therefore, it is necessary to restart the smallpox vaccination program in high risk populations.